Pain Management With Virtual Reality Hypnosis

NCT06502457 | Recruiting

• 1 other identifier: PI2024_843_0067
• Study Type: interventional
• Target: 142
• Locations: 1 country
• Sites: 1

Brief Summary

The latency phase corresponds to the first phase of the first stage of labour, during which the parturient feels regular, rhythmic uterine contractions that are often painful, with or without changes of the cervix. This phase lasts an average of 8 hours for primiparous women, compared with 5 hours for multiparous women, and can last up to twenty hours in total. Cervical ripening corresponds to the medical induction of regular, painful uterine contractions in order to obtain a favourable cervix for the induction of labour. Cervical ripening is carried out either medically (oral or local prostaglandins) or mechanically (double balloon dilatation) and accounts for 69.2% of labour inductions, which in turn account for 25.8% of births. At Amiens-Picardie University Hospital, this maturation stage can last from a few hours to 2 days, depending on the service protocol. What these two stages of childbirth have in common is that they are both painful, with very few analgesic drugs available that can be used without side-effects on the foetus during pregnancy. In recent years, there has also been a growing demand from parturients for the use of non-medicinal therapies. It therefore seems essential to provide parturients with as many effective non-drug methods as possible to manage their pain properly. If virtual reality hypnosis sessions prove to be effective, they will provide better pain management for women in labour, reduce the use of morphine derivatives (with their attendant side-effects, particularly on the foetus), and above all meet the growing demand from women in labour for the most physiological possible support during childbirth.

Conditions

Hypnosis; Labor Pain; Virtual Reality; Labor Induction; Latent Period

Keywords

hypnosis; labor pain; virtual reality; labor induction; latent period

Outcome Measures

Primary Outcomes (1)

• pain intensity difference between the first analgesic procedure and 30min later

  Assessment of PID (pain intensity difference) between the first analgesic procedure and 30min later.

  30 minutes

Secondary Outcomes (1)

• Average consumption of analgesics

  12 hours

Study Arms (2)

control group

ACTIVE COMPARATOR

Drug: painkiller

hypnosis group

EXPERIMENTAL

Other: hypnosis group

Interventions

painkiller DRUG

The control group will receive a painkiller adapted to the service protocol after the fetal heart rate has been recorded.

control group

hypnosis group OTHER

The hypnosis group will receive a hypnosis session after the fetal heart rate has been recorded. Automated measurement of blood pressure and maternal heart rate will take place during the session in order to objectively assess the impact of the session on the mother. Patients in the hypnosis group will then have access to the virtual reality headset on request throughout the latency or maturation phase, and will also be able to benefit from a painkiller in accordance with the service protocol if they so request.

hypnosis group

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Parturient over 18
• Parturient who speaks and understands French
• Parturient hospitalised prior to labour
• Membranes intact or ruptured
• Spontaneous or induced labour
• Parturient in latency phase
• Term ≥ 37SA
• END \> 3
• Parturient requiring active pain management (medicinal or non-medicinal)
• Low-risk pregnancy

You may not qualify if:

• Parturient under legal protection
• Parturient with a hearing impairment
• Parturient with visual impairment
• Parturient with epilepsy
• Parturient with psychiatric problems
• Pathological pregnancy
• Parturient with chronic pain
• Parturient with addiction-related disorders
• Parturient allergic to paracetamol
• Parturient allergic to phloroglucinol
• Parturient allergic to codeine
• Parturient allergic to nalbuphine
• Parturient allergic to orozamudol

Sponsors & Collaborators

• Centre Hospitalier Universitaire, Amiens: lead

Study Sites (1)

CHU Amiens Picardie

Amiens, France

RECRUITING

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 9, 2024
• First Posted: July 16, 2024
• Study Start: July 9, 2024
• Primary Completion: July 1, 2025
• Study Completion: August 1, 2025
• Last Updated: May 25, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)